EA201892503A1 - Модуляция метаболизма липидов для продуцирования белков - Google Patents

Модуляция метаболизма липидов для продуцирования белков

Info

Publication number
EA201892503A1
EA201892503A1 EA201892503A EA201892503A EA201892503A1 EA 201892503 A1 EA201892503 A1 EA 201892503A1 EA 201892503 A EA201892503 A EA 201892503A EA 201892503 A EA201892503 A EA 201892503A EA 201892503 A1 EA201892503 A1 EA 201892503A1
Authority
EA
Eurasian Patent Office
Prior art keywords
lipid metabolism
modulation
cell
present
protein production
Prior art date
Application number
EA201892503A
Other languages
English (en)
Russian (ru)
Inventor
Джеймс Бадж
Кристофер Марк Смейлз
Таня Найт
Роберт Янг
Original Assignee
Лонца Лтд
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лонца Лтд filed Critical Лонца Лтд
Publication of EA201892503A1 publication Critical patent/EA201892503A1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0097Oxidoreductases (1.) acting on reduced flavodoxin as donor (1.19)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0681Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0083Miscellaneous (1.14.99)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y114/00Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/19Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water (1.14.19)
    • C12Y114/19001Stearoyl-CoA 9-desaturase (1.14.19.1), i.e. DELTA9-desaturase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EA201892503A 2016-05-03 2017-05-03 Модуляция метаболизма липидов для продуцирования белков EA201892503A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662330973P 2016-05-03 2016-05-03
PCT/EP2017/060484 WO2017191165A1 (en) 2016-05-03 2017-05-03 Modulation of lipid metabolism for protein production

Publications (1)

Publication Number Publication Date
EA201892503A1 true EA201892503A1 (ru) 2019-09-30

Family

ID=58745198

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201892503A EA201892503A1 (ru) 2016-05-03 2017-05-03 Модуляция метаболизма липидов для продуцирования белков

Country Status (13)

Country Link
US (3) US10655111B2 (enExample)
EP (1) EP3452608B1 (enExample)
JP (1) JP6959942B2 (enExample)
KR (1) KR102536221B1 (enExample)
CN (1) CN109415748A (enExample)
AU (1) AU2017259010B2 (enExample)
CA (1) CA3023038C (enExample)
EA (1) EA201892503A1 (enExample)
ES (1) ES2938626T3 (enExample)
IL (2) IL294241B2 (enExample)
MX (1) MX2018013499A (enExample)
SG (1) SG11201809626PA (enExample)
WO (1) WO2017191165A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2938626T3 (es) 2016-05-03 2023-04-13 Lonza Ag Modulación del metabolismo de los lípidos para la producción de proteínas
ES2871818T3 (es) * 2018-02-02 2021-11-02 Lonza Ag Métodos de selección celular y modificación del metabolismo celular
US20210324366A1 (en) * 2018-07-11 2021-10-21 Cornell University Supported plant plasma membrane lipid bilayer on-a-chip
CN120795059A (zh) 2018-08-27 2025-10-17 瑞泽恩制药公司 拉曼光谱在下游纯化中的应用
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
CN113348248B (zh) * 2018-10-24 2024-12-31 思兰克斯有限公司 表达系统、重组细胞及其用途
JP7574206B2 (ja) 2019-03-20 2024-10-28 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ステロール調節エレメント結合転写因子1(srebf1)阻害剤による上昇した脂質レベルの治療
CN110317799B (zh) * 2019-07-18 2026-04-03 江南大学 一种人源岩藻糖转移酶8的原核表达方法及其产品
US20220403398A1 (en) 2019-11-14 2022-12-22 Lonza Ltd Methods of cell selection
CN115029307A (zh) * 2022-07-28 2022-09-09 吉林大学 一种延缓MSCs衰老的方法
WO2026062080A1 (en) 2024-09-17 2026-03-26 Ares Trading S.A. Cell having increased secretion capabilities and method of use

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
JP3614866B2 (ja) 1997-06-12 2005-01-26 リサーチ コーポレイション テクノロジーズ,インコーポレイティド 人工抗体ポリペプチド
EP1235842A4 (en) 1999-10-15 2003-04-23 Univ Massachusetts Rna interference pathway genes as tools for targeted genetic interference
US6326193B1 (en) 1999-11-05 2001-12-04 Cambria Biosciences, Llc Insect control agent
AU2001275474A1 (en) 2000-06-12 2001-12-24 Akkadix Corporation Materials and methods for the control of nematodes
AU2002321989A1 (en) 2001-02-02 2002-12-03 Bayer Corporation Methods of modulating surfactant phospholipid production
JP2007500016A (ja) * 2003-06-11 2007-01-11 バイオジェン・アイデック・エムエイ・インコーポレイテッド 培養においてタンパク質生成を増大させるための方法
JP4783359B2 (ja) 2004-04-16 2011-09-28 ディーエスエム アイピー アセッツ ビー.ブイ. 真菌細胞において遺伝子を発現させるための真菌プロモーター
EP1915394B1 (en) * 2005-05-20 2021-01-27 Lonza Biologics plc. High-level expression of recombinant antibody in a mammalian host cell
US20080182249A1 (en) * 2006-09-01 2008-07-31 Fox Brian G Expression systems for mammalian and mycobacterial desaturases
EP2209891A1 (en) 2007-11-13 2010-07-28 Boehringer Ingelheim Pharma GmbH & Co. KG Improving the secretory capacity in host cells
US8809559B2 (en) * 2008-11-18 2014-08-19 Commonwelath Scientific And Industrial Research Organisation Enzymes and methods for producing omega-3 fatty acids
HUE043103T2 (hu) * 2013-02-01 2019-08-28 Selexis Sa Fokozott transzgén expresszió és processzálás
CN105849265B (zh) * 2013-08-06 2021-03-26 英国龙沙生物医药股份有限公司 用于产生供生产重组蛋白的哺乳动物生产细胞的物品和方法
ES2938626T3 (es) * 2016-05-03 2023-04-13 Lonza Ag Modulación del metabolismo de los lípidos para la producción de proteínas

Also Published As

Publication number Publication date
CA3023038A1 (en) 2017-11-09
BR112018072434A2 (pt) 2019-02-19
US10655111B2 (en) 2020-05-19
US11434474B2 (en) 2022-09-06
EP3452608A1 (en) 2019-03-13
IL294241B2 (en) 2023-10-01
AU2017259010A1 (en) 2018-11-22
US20200231944A1 (en) 2020-07-23
AU2017259010B2 (en) 2021-04-22
WO2017191165A1 (en) 2017-11-09
KR20190003651A (ko) 2019-01-09
EP3452608B1 (en) 2022-11-30
CN109415748A (zh) 2019-03-01
KR102536221B1 (ko) 2023-05-23
CA3023038C (en) 2023-03-14
SG11201809626PA (en) 2018-11-29
ES2938626T3 (es) 2023-04-13
JP2019514399A (ja) 2019-06-06
IL262646A (en) 2018-12-31
IL294241B1 (en) 2023-06-01
IL294241A (en) 2022-08-01
IL262646B (en) 2022-08-01
JP6959942B2 (ja) 2021-11-05
MX2018013499A (es) 2019-09-11
US20230047838A1 (en) 2023-02-16
US20170321194A1 (en) 2017-11-09

Similar Documents

Publication Publication Date Title
MX2018013499A (es) Modulacion del metabolismo lipidico para la produccion de proteinas.
EA201791782A1 (ru) 4,6-диаминопиридо[3,2-d]пиримидиновые соединения, модулирующие toll-подобные рецепторы
HK1254803A1 (zh) 新型pd -1的免疫调节剂
WO2018049009A3 (en) Modulation of liver genes
AU2017263237A1 (en) GDF15 fusion proteins and uses thereof
MX2019002946A (es) Anticuerpos anti-pd-1 y sus usos.
MY192561A (en) Taurine supplemented cell culture medium and methods of use
EA201991976A1 (ru) Метаболически оптимизированная клеточная культура
EP4311857A3 (en) Recombinant host cell engineered to overexpress helper proteins
MX2021008142A (es) Metodos para cosechar cultivos de celulas de mamifero.
SA520412669B1 (ar) تصنيع ذيفانات عصبية ناتجة عن معاودة الارتباط الجيني من المطثية الوشيقية
WO2014116846A3 (en) Methods and compositions for modulating an immune response
EP4674866A3 (en) Compositions and methods for growth factor modulation
EA201892820A1 (ru) Способ стабилизации белков
ECSP077898A (es) Métodos y composiciones para modular la adhesión y la tolerancia al estrés en bacterias
BR112016023769A2 (pt) célula hospedeira recombinante para a expressão de proteínas de interesse
PH12020550483A1 (en) Anti-apoc3 antibodies and methods of use thereof
AU2018289493A1 (en) Methods for modulating regulatory T cells, regulatory B cells, and immune responses using modulators of the APRIL-TACI interaction
HK1247958A1 (zh) T淋巴细胞的调节
WO2020205626A8 (en) Modulators of cell surface protein interactions and methods and compositions related to same
MX2016009149A (es) Variantes mejoradas de enzimas.
EA201791918A1 (ru) Модификация белков клеток-хозяев
EA202190736A1 (ru) Способы и композиции для увеличения экспрессии белка и/или лечения расстройства, связанного с гаплонедостаточностью
MX2019002307A (es) Anticuerpos multiespecificos que facilitan el emparejamiento selectivo de cadenas ligeras.
MX377780B (es) Sobreexpresion de reguladores de la ruta de n-glicosilacion para modular la glicosilacion de proteinas recombinantes.